Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol

Hang Zhao,1 Linyi Shu,2 Wenli Huang,2 Wenzhao Wang,2 Guangyao Song1 1Endocrinology Department, Hebei General Hospital, Shijiazhuang, Hebei 050051, People’s Republic of China; 2Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, People’s Republic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhao H, Shu L, Huang W, Wang W, Song G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/df8c9627395a4e199d191b97576a517e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:df8c9627395a4e199d191b97576a517e
record_format dspace
spelling oai:doaj.org-article:df8c9627395a4e199d191b97576a517e2021-12-02T06:29:50ZDifference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol1178-7007https://doaj.org/article/df8c9627395a4e199d191b97576a517e2019-10-01T00:00:00Zhttps://www.dovepress.com/difference-analysis-of-related-factors-in-macrovascular-and-microvascu-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Hang Zhao,1 Linyi Shu,2 Wenli Huang,2 Wenzhao Wang,2 Guangyao Song1 1Endocrinology Department, Hebei General Hospital, Shijiazhuang, Hebei 050051, People’s Republic of China; 2Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, People’s Republic of ChinaCorrespondence: Guangyao SongEndocrinology Department, Hebei General Hospital, 348 Heping West Road, Shijiazhuang, Hebei 050051, People’s Republic of ChinaTel +86 311 85988556Email guangyaosong123@163.comIntroduction: Despite the increasingly young age at diabetes onset and the increasing number of deaths caused by type 2 diabetes mellitus (T2DM), why some patients develop macrovascular complications but others develop microvascular complications remains controversial and unclear. Notably, some patients have good glucose control but still develop vascular complications, whereas some patients have retinopathy with neither nephropathy nor neuropathy. This study will be performed to explore the risk factors for T2DM complications in Chinese patients.Methods and analysis: Patients with T2DM and healthy people will be recruited from Hebei General Hospital from September 2019 to September 2020. The subjects will be grouped into a control group, T2DM without vascular complications group, T2DM with macrovascular complications group, and T2DM with microvascular complications group; they will then be further subgrouped. The following data will be collected after admission: demographic information such as age, sex, and education; relevant medical history such as duration of diabetes, family history of first-degree relatives with diabetes, and age at diagnosis of diabetes; and anthropometric and blood indicators such as weight, waist circumference, fasting blood glucose level, C-peptide level, total cholesterol level, and triglyceride level. The statistical analysis will be performed using SPSS 22.0 (IBM Corp., Armonk, NY, USA). A P value of <0.05 will be considered statistically significant. The χ2 test, one-way analysis of variance and the rank sum test will be used to analyze differences between the groups. Logistic regression will be used to analyze the risk factors for macrovascular and microvascular complications of T2DM.Keywords: diabetes mellitus, type 2, diabetic angiopathies, risk factorsZhao HShu LHuang WWang WSong GDove Medical PressarticleDiabetes MellitusType 2Diabetic AngiopathiesRisk FactorsSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 2193-2200 (2019)
institution DOAJ
collection DOAJ
language EN
topic Diabetes Mellitus
Type 2
Diabetic Angiopathies
Risk Factors
Specialties of internal medicine
RC581-951
spellingShingle Diabetes Mellitus
Type 2
Diabetic Angiopathies
Risk Factors
Specialties of internal medicine
RC581-951
Zhao H
Shu L
Huang W
Wang W
Song G
Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
description Hang Zhao,1 Linyi Shu,2 Wenli Huang,2 Wenzhao Wang,2 Guangyao Song1 1Endocrinology Department, Hebei General Hospital, Shijiazhuang, Hebei 050051, People’s Republic of China; 2Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, People’s Republic of ChinaCorrespondence: Guangyao SongEndocrinology Department, Hebei General Hospital, 348 Heping West Road, Shijiazhuang, Hebei 050051, People’s Republic of ChinaTel +86 311 85988556Email guangyaosong123@163.comIntroduction: Despite the increasingly young age at diabetes onset and the increasing number of deaths caused by type 2 diabetes mellitus (T2DM), why some patients develop macrovascular complications but others develop microvascular complications remains controversial and unclear. Notably, some patients have good glucose control but still develop vascular complications, whereas some patients have retinopathy with neither nephropathy nor neuropathy. This study will be performed to explore the risk factors for T2DM complications in Chinese patients.Methods and analysis: Patients with T2DM and healthy people will be recruited from Hebei General Hospital from September 2019 to September 2020. The subjects will be grouped into a control group, T2DM without vascular complications group, T2DM with macrovascular complications group, and T2DM with microvascular complications group; they will then be further subgrouped. The following data will be collected after admission: demographic information such as age, sex, and education; relevant medical history such as duration of diabetes, family history of first-degree relatives with diabetes, and age at diagnosis of diabetes; and anthropometric and blood indicators such as weight, waist circumference, fasting blood glucose level, C-peptide level, total cholesterol level, and triglyceride level. The statistical analysis will be performed using SPSS 22.0 (IBM Corp., Armonk, NY, USA). A P value of <0.05 will be considered statistically significant. The χ2 test, one-way analysis of variance and the rank sum test will be used to analyze differences between the groups. Logistic regression will be used to analyze the risk factors for macrovascular and microvascular complications of T2DM.Keywords: diabetes mellitus, type 2, diabetic angiopathies, risk factors
format article
author Zhao H
Shu L
Huang W
Wang W
Song G
author_facet Zhao H
Shu L
Huang W
Wang W
Song G
author_sort Zhao H
title Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
title_short Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
title_full Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
title_fullStr Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
title_full_unstemmed Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
title_sort difference analysis of related factors in macrovascular and microvascular complications in chinese patients with type 2 diabetes mellitus: a case-control study protocol
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/df8c9627395a4e199d191b97576a517e
work_keys_str_mv AT zhaoh differenceanalysisofrelatedfactorsinmacrovascularandmicrovascularcomplicationsinchinesepatientswithtype2diabetesmellitusacasecontrolstudyprotocol
AT shul differenceanalysisofrelatedfactorsinmacrovascularandmicrovascularcomplicationsinchinesepatientswithtype2diabetesmellitusacasecontrolstudyprotocol
AT huangw differenceanalysisofrelatedfactorsinmacrovascularandmicrovascularcomplicationsinchinesepatientswithtype2diabetesmellitusacasecontrolstudyprotocol
AT wangw differenceanalysisofrelatedfactorsinmacrovascularandmicrovascularcomplicationsinchinesepatientswithtype2diabetesmellitusacasecontrolstudyprotocol
AT songg differenceanalysisofrelatedfactorsinmacrovascularandmicrovascularcomplicationsinchinesepatientswithtype2diabetesmellitusacasecontrolstudyprotocol
_version_ 1718399904849592320